Nikhil C. Munshi
0000-0002-7344-9795
Publication & Citation Trends
Publications
0 total
Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens (SRs) in Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3 Subanalysis of Black Patients (pts)
Cited by 1
Semantic Scholar
MM-359 Idecabtagene Vicleucel (Ide-Cel) Versus Standard Regimens (SRs) in Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3 Sub-Analysis of Black Patients
Cited by 0
Semantic Scholar
Biomarker Correlates of 3 Year Response in Cartitude-1: A Phase 1b/2 Open-Label Study of Ciltacabtagene Autoleucel in Patients with Relapsed or Refractory Multiple Myeloma
Cited by 1
Semantic Scholar
POSTER: MM-304 Efficacy Outcomes and Characteristics of Patients With Multiple Myeloma (MM) Who Achieved Sustained Minimal Residual Disease Negativity After Treatment With Ciltacabtagene Autoleucel (cilta-cel) in CARTITUDE-1 OA
Cited by 0
Semantic Scholar
MM-304 Efficacy Outcomes and Characteristics of Patients With Multiple Myeloma (MM) Who Achieved Sustained Minimal Residual Disease Negativity After Treatment With Ciltacabtagene Autoleucel (cilta-cel) in CARTITUDE-1
Cited by 0
Semantic Scholar
Oral Abstract: MM-304 Efficacy Outcomes and Characteristics of Patients With Multiple Myeloma (MM) Who Achieved Sustained Minimal Residual Disease Negativity After Treatment With Ciltacabtagene Autoleucel (cilta-cel) in CARTITUDE-1 OA
Cited by 0
Semantic Scholar
Supplementary File 4 OA
Cited by 171
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(985)
Protein Degradation and Inhibitors
(344)
Peptidase Inhibition and Analysis
(178)
CAR-T cell therapy research
(148)
Immunotherapy and Immune Responses
(135)
Affiliations
University of Siena
University of Arkansas at Little Rock
Dartmouth College
Boston University
University of Maryland, Baltimore